【4月文獻(xiàn)戰(zhàn)報(bào)】Bioss抗體新增高分文獻(xiàn)精彩呈現(xiàn)-商家動態(tài)-資訊-生物在線

【4月文獻(xiàn)戰(zhàn)報(bào)】Bioss抗體新增高分文獻(xiàn)精彩呈現(xiàn)

作者：北京博奧森生物技術(shù)有限公司 2023-06-21T09:37 (訪問量:13289)

截止目前，引用Bioss產(chǎn)品發(fā)表的文獻(xiàn)共24858篇，總影響因子116841.414分，發(fā)表在Nature, Science, Cell以及Immunity等頂級期刊的文獻(xiàn)共58篇，合作單位覆蓋了清華、北大、復(fù)旦、華盛頓大學(xué)、麻省理工學(xué)院、東京大學(xué)以及紐約大學(xué)等國際知名研究機(jī)構(gòu)上百所。

我們每月收集引用Bioss產(chǎn)品發(fā)表的文獻(xiàn)。若您在當(dāng)月已發(fā)表SCI文章，但未被我公司收集，請致電Bioss，我們將贈予現(xiàn)金鼓勵，金額標(biāo)準(zhǔn)請參考“發(fā)文章領(lǐng)獎金”活動頁面。

近期收錄2023年4月引用Bioss產(chǎn)品發(fā)表的文獻(xiàn)共288篇（圖一，綠色柱），文章影響因子(IF) 總和高達(dá)2009.871，其中，10分以上文獻(xiàn)47篇（圖二）。

圖一

圖二

本文主要分享引用Bioss產(chǎn)品發(fā)表文章至Nature Nanotechnology, Immunity, Cancer Cell等期刊的5篇 IF＞15 的文獻(xiàn)摘要，讓我們一起欣賞吧。

Cell Discovery [IF=38.079]

文獻(xiàn)引用抗體：bsm-41516M

Mouse Anti- SARS-CoV-2 (2019-nCoV) Spike RBD mAb | WB

作者單位：北京大學(xué)未來技術(shù)學(xué)院生物醫(yī)學(xué)工程系

摘要：Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has elicited a worldwide pandemic since late 2019. There has been ~675 million confirmed coronavirus disease 2019 (COVID-19) cases, leading to more than 6.8 million deaths as of March 1, 2023. Five SARS-CoV-2 variants of concern (VOCs) were tracked as they emerged and were subsequently characterized. However, it is still difficult to predict the next dominant variant due to the rapid evolution of its spike (S) glycoprotein, which affects the binding activity between cellular receptor angiotensin-converting enzyme 2 (ACE2) and blocks the presenting epitope from humoral monoclonal antibody (mAb) recognition. Here, we established a robust mammalian cell-surface-display platform to study the interactions of S-ACE2 and S-mAb on a large scale. A lentivirus library of S variants was generated via in silico chip synthesis followed by site-directed saturation mutagenesis, after which the enriched candidates were acquired through single-cell fluorescence sorting and analyzed by third-generation DNA sequencing technologies. The mutational landscape provides a blueprint for understanding the key residues of the S protein binding affinity to ACE2 and mAb evasion. It was found that S205F, Y453F, Q493A, Q493M, Q498H, Q498Y, N501F, and N501T showed a 3–12-fold increase in infectivity, of which Y453F, Q493A, and Q498Y exhibited at least a 10-fold resistance to mAbs REGN10933, LY-CoV555, and REGN10987, respectively. These methods for mammalian cells may assist in the precise control of SARS-CoV-2 in the future.

JOURNAL OF HEPATOLOGY

[IF=30.083]

文獻(xiàn)引用抗體：bs-1278R

Anti-8-OHdG (DNA/RNA Damage) pAb | IHC

作者單位：美國明尼蘇達(dá)州羅切斯特市梅奧診所生物化學(xué)和分子生物學(xué)部

摘要：Background & Aims

The prevalence of non-alcoholic steatohepatitis (NASH)-driven hepatocellular carcinoma (HCC) is rising rapidly, yet its underlying mechanisms remain unclear. Herein, we aim to determine the role of hypoxia-inducible lipid droplet associated protein (HILPDA)/hypoxia-inducible gene 2 (HIG2), a selective inhibitor of intracellular lipolysis, in NASH-driven HCC.

Methods

The clinical significance of HILPDA was assessed in human NASH-driven HCC specimens by immunohistochemistry and transcriptomics analyses. The oncogenic effect of HILPDA was assessed in human HCC cells and in 3D epithelial spheroids upon exposure to free fatty acids and either normoxia or hypoxia. Lipidomics profiling of wild-type and HILPDA knockout HCC cells was assessed via shotgun and targeted approaches. Wild-type (Hilpda^fl/fl) and hepatocyte-specific Hilpda knockout

北京博奧森生物技術(shù)有限公司商家主頁

地址：北京市通州區(qū)馬駒橋鎮(zhèn)聯(lián)東U谷西區(qū)四期67號樓

聯(lián)系人：秦

電話： 4009019800

傳真： 010-58129612

Email：sales@bioss.com.cn

女人与狗锁死了视频大全|霍金死亡过程恐怖视频|无节社团简谱季免费观看|六间房直播大厅|中文字幕欧美另类精品|久久人人玩人妻潮喷内射人人|亚洲国产一区二区三区在线观看